Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Not yet recruiting 2No longer available 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Myelodysplastic Syndromes 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Acute 11Multiple Myeloma 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma, Non-Hodgkin 6Lymphoma 6Myeloproliferative Disorders 5Hodgkin Disease 5Leukemia, Myelomonocytic, Juvenile 4Leukemia 4Precancerous Conditions 3Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Hematologic Neoplasms 3Burkitt Lymphoma 3Anemia, Aplastic 3Waldenstrom Macroglobulinemia 2Smoldering Multiple Myeloma 2Recurrence 2Primary Myelofibrosis 2Preleukemia 2Neoplasms by Histologic Type 2Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

pembrolizumab 5Nivolumab 3Ipilimumab 3lenvatinib 2trametinib 1tislelizumab 1tebentafusp 1spartalizumab 1ruxolitinib 1omipalisib 1binimetinib 1belinostat 1avelumab 1Vorinostat 1Valproic Acid 1Tape Recording 1Sunitinib 1Solutions 1Practice Guidelines as Topic 1Pemetrexed 1Methods 1Melphalan 1Iodized Oil 1Health Promotion 1GSK2141795 1Ethiodized Oil 1Epilim 1Educational Status 1Diet Therapy 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Uveal Melanoma × Melphalan × Clear all
NCT05022901 2023-12-21

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Delcath Systems Inc.

Phase 3 Active not recruiting
30 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡